Soligenix, Inc.
🏢 View company profile →15Patents
13Active
15Granted
46Portfolio score
Filing activity: Mar 15, 2002 → Sep 2, 2022 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8263582B2 | Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids | Human Necessities | 5 | Expired |
| US8535650B2 | Stabilized reverse micelle compositions and uses thereof | Human Necessities | 4 | Expired |
| US11433129B2 | Compositions and methods of manufacturing trivalent filovirus vaccines | Emerging Cross-Sectional Technologies | 1 | Active |
| US12097291B2 | Thermostable vaccine compositions and methods of preparing same | Emerging Cross-Sectional Technologies | 1 | Active |
| US9763963B2 | Topically active steroids for use in interstitial pulmonary fibrosis | Human Necessities | 0 | Active |
| US8791061B2 | Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity | Emerging Cross-Sectional Technologies | 0 | Active |
| US11771757B2 | Compositions and methods of manufacturing trivalent filovirus vaccines | Emerging Cross-Sectional Technologies | 0 | Active |
| US9168263B2 | Topically active steroids for use in interstitial pulmonary fibrosis | Human Necessities | 0 | Active |
| US10053413B2 | Systems and methods for producing synthetic hypericin | Chemistry; Metallurgy | 0 | Active |
| US10526268B2 | Systems and methods for producing synthetic hypericin | Chemistry; Metallurgy | 0 | Active |
| US9416157B2 | Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity | Emerging Cross-Sectional Technologies | 0 | Active |
| US9850279B2 | Peptides and analogs for use in the treatment of oral mucositis | Chemistry; Metallurgy | 0 | Active |
| US11311598B2 | Peptides and analogs for use in the treatment of oral mucositis | Human Necessities | 0 | Active |
| US10253068B2 | Peptides and analogs for use in the treatment of oral mucositis | Chemistry; Metallurgy | 0 | Active |
| US10293041B2 | Multivalent stable vaccine composition and methods of making same | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.